Previous Issue - Issue 52
Issue 52 | 2023
- Foreword
- Strategy
- Research & Development
- Clinical Trials
- Manufacturing
- Advertorials Go to Digital Magazine
Issue 52
PREVIOUS ISSUE
Strategy
THE GLOCALISATION CLASSROOM
Astute glocalisers learn from their successes and failures
In the first article in this series The Glocalisation Challenge I differentiated between astute and nave glocalisers and in this fourth and final article
Research & Development
Emerging Tools Shaping Drug Discovery and Development Landscape
Rapid scientific and technological innovations have enabled us to manipulate complex living systems and expanded our understanding of human biology
Adopting the Power of AI to Drug Development Projects
A tremendous amount of documentation is created throughout the clinical trial lifecycle
Respirable Engineered Spray Dried Dry Powder as a Platform Technology
The dichotomous branching of the lungs from the th generation the trachea to the rd generation of the lungs offers a surface area of m of the alveolar region
Clinical Trials
Human Challenge Trials
Establishing early risk-benefit in development of vaccines and therapies for infectious diseases
Although slowly fading away from the collective memory the SARSCoV pandemic that started in early and the unprecedented health crisis on a global scale that followed reminded us about the necessity of pandemic preparedness
Manufacturing
Just in Time Manufacturing Creating more sustainable supply chains
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
